Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study.
Roussel R, Darmon P, Pichelin M, Goronflot T, Abouleka Y, Ait Bachir L, Allix I, Ancelle D, Barraud S, Bordier L, Carlier A, Chevalier N, Coffin-Boutreux C, Cosson E, Dorange A, Dupuy O, Fontaine P, Fremy B, Galtier F, Germain N, Guedj AM, Larger E, Laugier-Robiolle S, Laviolle B, Ludwig L, Monier A, Montanier N, Moulin P, Moura I, Prevost G, Reznik Y, Sabbah N, Saulnier PJ, Serusclat P, Vatier C, Wargny M, Hadjadj S, Gourdy P, Cariou B; CORONADO investigators.
Roussel R, et al. Among authors: monier a.
Diabetes Obes Metab. 2021 May;23(5):1162-1172. doi: 10.1111/dom.14324. Epub 2021 Feb 16.
Diabetes Obes Metab. 2021.
PMID: 33528920
Free PMC article.